Abiopharma

🔍 Sela Ofer (Director)

Company: Maris Tech Ltd. (MTEK)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 35,495 shares of Ordinary shares (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 35,495.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,500 shares of Share Option at $1.165 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2031-08-16 | equity_swap_involved: 0 | shares_owned_after: 7,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents 35,495 restricted share units ("RSUs") granted to the Reporting Person on August 17, 2026. Each RSU represents the right to receive one Ordinary Share upon vesting. The RSUs vest in four equal quarterly installments of 25% each, commencing October 1, 2026, with vesting measured from July 1, 2026, subject to continued service.
• F2: The options were granted on August 17, 2026, have an exercise price of $1.165 per share and expire on August 16, 2031. Fifty percent (50%) vest on July 13, 2028, and the remaining fifty percent (50%) vest in eight equal quarterly installments thereafter, subject to continued service.